| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |